[1] 陈孜瑾, 蒋钻红, 汪知玉, 等. 超声评估维持性血液透析患者甲状旁腺增生的临床价值和相关因素分析[J]. 中国血液净化,2017,16(2):108-112.
[2] Okada M, Tominaga Y, Hiramitsu T, et al.Development of severe hyper-parathyroidism despite short-term renal replacement therapy[J]. World J Surg,2018,42(2):425-430.
[3] Zhang L, Fang W, Li W, et al.Prevalence of chronic kidney disease in China[J]. Lancet,2012,379(9818):815-822.
[4] 张凌, 常靓. 西那卡塞在CKD-MBD 中的应用[J]. 临床药物治疗杂志,2017,15(4):7-10.
[5] Kidney DiseaseI improving Global outcomes (KDIGO) CKD-MBD Work Group. Clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J]. Kidney Int Suppl,2009,76(Suppl 113):S1-S130.
[6] 中华医学会肾脏病学分会. 慢性肾脏病矿物质和骨异常诊治指导[J]. 肾脏病与透析肾移植杂志,2013,22(6):554-559.
[7] 薄天慧, 赵伟, 高秀. 高通量血液透析联合血液灌流对维持性血液透析患者血清钙、磷及甲状旁腺激素代谢的影响[J]. 国际移植与血液净化杂志,2017,15(4):34-36.
[8] Floege J, Kubo Y, Floege A, et al.The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: The EVOLVE trial[J]. Clin J Am Soc Nephrol,2015,10(5):800-807.
[9] van der Plas WY, Engelsman AF, Özyilmaz A, et al. Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism[J]. Ann Surg Oncol,2017,24(1):15-22.
[10] Isaksson E, Ivarsson K, Akaberi S, et al.The effect of parathyroidectomy on risk of hip fracture in secondary hyperparathyroidism[J]. World J Surg,2017,41(9):2304-2311.
[11] Iwamoto N, Sato N, Nishida M, et al.Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients[J]. Clin Exp Nephrol,2016,20(5):808-814.
[12] Chen L, Wang K, Yu S, et al.Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis[J]. Ren Fail,2016,38(7):1050-1058.
[13] Apetrii M, Goldsmith D, Nistor I, et al.Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder(CKD-MBD)- A systematic review and meta-analysis[J]. PLoS One,2017,12(11):e0187025.
[14] Schneider R, Kolios G, Koch BM, et al.An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism-the German prospective[J]. Surgery,2010,148(6):1091-1099.
[15] van der Plas WY, Dulfer RR, Engelsman AF, et al. Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review[J]. Nephrol Dial Transplant,2017,32(11):1902-1908.
[16] Fülöp T, Koch CA, Farah Musa AR, et al. Targeted surgical parathyroidectomy in end-stage renal disease patients and long-term metabolic control: A single-center experience in the current era[J]. Hemodial Int,2018-02-15 [Epub ahead of print]
[17] 杨镇玮, 白超, 罗军. 手术与拟钙剂治疗难治性SHPT的短期疗效比较[J]. 重庆医学,2017,46(9):1214-1219.
[18] Fukagawa M, Yokoyama K, Koiwa F, et al.Clinical practice guideline for the management of chronic kidney disease mineral and bone disorder[J]. Ther Apher Dial,2013,17(3):247-288.
[19] 中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志,2016,36(5):481-486.
[20] Kravietz AM, Buicko JL, Parreco JP, et al. Thirty-day readmissions following parathyroidectomy: Evidence from the National Readmissions Database, 2013-2014[J]. Am J Otolaryngol,2018-01-10[Epub ahead of print]
[21] Doyle DJ, Garmon EH.American Society of Anesthesio-logists Classification(ASA Class)[M]. Treasure Island (FL): Stat Pearls Publishing,2018.
[22] 杨猛, 张凌, 黄林平, 等. 无自体移植的甲状旁腺全切除术在难治性继发性甲状旁腺功能亢进中的应用[J]. 中国现代普通外科进展,2017,20(5):342-345.
[23] 梁伟, 李朋, 熊子波, 等. 维持性透析患者甲状旁腺切除术后低钙血症相关因素分析[J]. 中国血液净化,2017,16(2):91-94.
[24] Chan GC, Lee PC, Kwan LP, et al.Acute thyroiditis: An under-recognized complication of parathyroidectomy in end-stage renal failure patients with secondary hyperparathyroidism[J]. Nephrology (Carlton),2017,22(7):572.
[25] 章建全, 仇明, 盛建国, 等. 超声引导下经皮穿刺热消融治疗甲状旁腺结节[J]. 第二军医大学学报,2013,34(4):362-370.
[26] 麻昊旸, 程晨, 王宁宁, 等. 甲状旁腺热消融术治疗严重继发性甲状旁腺功能亢进[J]. 肾脏病与透析肾移植杂志,2017,26(4):370-375.
[27] Kim SM, Long J, Montez-Rath ME, et al.Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States[J]. Clin J Am Soc Nephrol,2016,11(7):1260-1267.
